SonoVascular announced today that it completed the first close of its $6 million Series A financing round. Harbright Ventures served as leading investor. Following the round, Robert Ross, Harbright’s founding partner, joined SonoVascular’s board of directors. The Chapel Hill, North Carolina-based company develops the SonoThrombectomy system … [Read more...] about SonoVascular raises $6M Series A to support thrombectomy system
Business
Freudenberg Medical launches new hydrophilic coating solution
Freudenberg Medical announced today that it launched Lubriteq, its new high-performance hydrophobic coating solution. The Beverly, Massachusetts-based company also launched a comprehensive suite of associated development and manufacturing services. It now offers Lubriteq globally across its vertically integrated operations. Freudenberg said … [Read more...] about Freudenberg Medical launches new hydrophilic coating solution
Medtronic to invest up to $90M in Anteris Technologies
Anteris Technologies (Nasdaq: AVR, ASX: AVR) says medtech giant Medtronic (NYSE: MDT) will make a strategic investment of up to $90 million in the transcatheter heart valve developer. The private placement, announced after market close yesterday, requires Medtronic to acquire a 16.0–19.99% stake in Anteris. In addition, Anteris is proposing a … [Read more...] about Medtronic to invest up to $90M in Anteris Technologies
Boston Scientific to acquire Penumbra for $14.5B
Boston Scientific (NYSE: BSX) today announced a definitive agreement to acquire cardiovascular disease treatment device maker Penumbra (NYSE:PEN). The deal values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion. Penumbra shares currently trade at approximately $313.43 apiece ahead of the market opening … [Read more...] about Boston Scientific to acquire Penumbra for $14.5B
Haemonetics acquires Irish vessel closure company Vivasure for $116.4M
Haemonetics (NYSE: HAE) announced today that it acquired percutaneous vessel closure device maker Vivasure Medical. Galway, Ireland-based Vivasure develops the PerQSeal Elite system, the first sutureless, fully absorbable synthetic implant for large-bore vessel punctures. Placement occurs from inside the vessel. It makes deployment simpler and … [Read more...] about Haemonetics acquires Irish vessel closure company Vivasure for $116.4M
W.L. Gore to acquire left atrial appendage device maker Conformal Medical
W.L. Gore & Associates announced today that it agreed to acquire left atrial appendage occlusion (LAAO) device maker Conformal Medical. The companies expect to close their deal early this year, subject to regulatory approval. Financial terms of the deal were not disclosed. Nashua, New Hampshire–based Conformal develops the CLAAS AcuForm … [Read more...] about W.L. Gore to acquire left atrial appendage device maker Conformal Medical
Transcatheter heart valves market to enjoy solid growth
The global, multibillion-dollar transcatheter heart valves market will grow at an 8.4% CAGR over the rest of the decade, according to MassDevice's latest Medtech Market Intelligence Report. Minimally invasive therapies have gained traction in the management of structural heart disease, and the field continues to evolve. The most established … [Read more...] about Transcatheter heart valves market to enjoy solid growth
Adagio Medical appoints longtime Medtronic exec Sean Salmon to board
Adagio Medical (Nasdaq:ADGM) announced that it appointed Sean Salmon to its board of directors. With his appointment, Salmon will also serve on the audit committee and compensation committee for the Laguna Hills, California-based company, which develops cryoablation technology for treating cardiovascular diseases. Adagio built its vCLAS … [Read more...] about Adagio Medical appoints longtime Medtronic exec Sean Salmon to board
Conmed to exit gastroenterology product lines, transfer Gore Viabil rights to Olympus
Conmed announced that it plans to exit its gastroenterology product lines as part of a broader portfolio optimization strategy. Part of the exit includes the end of the company's distribution agreement with W.L. Gore & Associates related to the Gore Viabil biliary endoprosthesis. That deal dates back to 2006. Olympus and Gore announced in … [Read more...] about Conmed to exit gastroenterology product lines, transfer Gore Viabil rights to Olympus
Procyrion adds former Silk Road Medical exec as new CCO
Procyrion announced today that it appointed Andrew Davis as its new chief commercial officer (CCO), effective immediately. Houston-based Procyrion develops a catheter-deployed percutaneous mechanical circulatory support (pMCS) device called Aortix. The company designed the device to treat patients with acute decompensated heart failure (ADHF) … [Read more...] about Procyrion adds former Silk Road Medical exec as new CCO
